Advertising Botox by Text and Email: FDA, FTC, TCPA and Carrier Rules

The question: is advertising Botox by text and email allowed for a med spa using GoHighLevel, and what rule governs each part? This is not legal advice. The honest short answer is that three separate rule sets apply and one of them, how FDA’s drug-advertising rules reach a clinic, is not answered on any FDA page we opened. Where the sources run out, this post says “ask counsel and your state medical board.” Sources were opened on October 15, 2026.

This post sits under our overview of med spa text and ad compliance in GoHighLevel. If you want an expert to configure the account, see GoHighLevel expert for med spas.

Is Botox a prescription drug, and why does that matter for advertising Botox by text and email?

Yes. FDA says FDA-approved botulinum toxin products, such as Botox, are “only available with a prescription from a licensed health care professional” (FDA press announcement, November 5, 2025). That announcement concerned 18 warning letters to websites selling unapproved and misbranded products. It does not mention clinics or med spas or their advertising, so it tells us the drug’s status, not the ad rules for a clinic.

The status matters in three places: federal drug-advertising rules, state medical board rules, and HighLevel’s carrier-facing rules for texting.

Do FDA’s prescription drug advertising rules cover a med spa’s own ads?

We could not confirm it from FDA’s pages, so ask counsel and your state medical board.

What the primary sources do say:

• FDA’s Office of Prescription Drug Promotion says its mission is to help ensure prescription drug promotion is “truthful, balanced, and accurately communicated,” and that it gives comments to “pharmaceutical sponsors.” The page does not address health care providers’ own promotion.
• The regulation, 21 CFR 202.1, refers to “an advertisement issued or caused to be issued by the manufacturer, packer, or distributor of the drug.” It also defines “reminder advertisements” as those that “call attention to the name of the drug product but do not include indications or dosage recommendations for use of the drug product.” That definition sits inside a rule written for those parties. We are not saying a clinic can rely on it.
• The FTC’s Health Products Compliance Guidance (page dated December 2022) says “The FDA has primary responsibility for claims that appear in labeling,” and “The FTC has primary responsibility for claims in all forms of advertising.” The parts we read do not address prescription drug advertising specifically.

So FDA’s rule text points at the manufacturer, the FTC’s general advertising authority covers claims in ads, and your state board may regulate physician advertising directly. How those fit together for a clinic’s own email is a question for a healthcare or advertising attorney.

What do the FTC and your state board add?

The FTC’s general rule applies to any ad: claims must be truthful and substantiated. The Health Products Compliance Guidance says health benefit claims need competent and reliable scientific evidence, and that testimonials that report results more dramatic than users can generally expect “are likely to be deceptive.” Our post on before-and-after photos and testimonials covers photos and reviews.

State medical boards vary. As an example only, the Medical Board of California’s article on medical spas says physician advertising must not be misleading, must carry the physician’s name, and that using models without saying so, using touched-up photos and using the phrase “for as low as” are prohibited. The article is undated and refers to 2006 and 2007 events, so confirm the current California Business and Professions Code section 651 with counsel (MBC article). We did not open any other state’s rules.

What does HighLevel say about prescription drugs in texts?

HighLevel’s help article “Understanding A2P Campaign Rejection Reasons & Required Fixes” lists “Prescription drugs or controlled substances” under Disallowed content with code 30941, in the group “not eligible for resubmission.” For forbidden or high-risk content it says “Do not resubmit the same Campaign” (HighLevel Support). It also lists “Deceptive marketing practices (false urgency, bait-and-switch, fake endorsements)” as a high-risk category (code 30962).

The article does not mention pharmacies, telehealth or clinics, so we cannot say how a med spa’s appointment texts are judged. Judgment, not a HighLevel rule: a rejection under a disallowed code costs weeks and cannot be resubmitted unchanged, so write the campaign description conservatively the first time. Practical steps:

1. Write the campaign description around what you actually send: appointment confirmations, reminders and follow-ups, with an accurate description of any promotions.
2. Keep drug names, doses and promotional claims out of sample messages unless counsel and HighLevel support confirm it is acceptable.
3. If a registration is rejected under a disallowed code, do not resubmit the same campaign. Follow HighLevel’s appeal route in the article and our A2P rejection guide.

What do texting and email rules require regardless of the product?

These apply to the message, whatever it promotes.

Texts. 47 CFR 64.1200 requires “prior express written consent” for autodialed or prerecorded telemarketing or advertising. That is a signed agreement that “clearly authorizes the seller,” lists the number, and says the person “is not required to sign” to buy anything. It defines telemarketing as a “call or message” encouraging purchase of goods or services. Revocation by STOP, QUIT, END, CANCEL or UNSUBSCRIBE must be honored, and calls for telephone solicitation are limited to 8 a.m. to 9 p.m. in the recipient’s local time. Our TCPA setup post shows the settings, including a note on pending FCC revocation changes.

Email. The FTC’s CAN-SPAM guide requires accurate header information, non-deceptive subject lines, identification of the message as an ad, a valid postal address, a clear opt-out honored within 10 business days, and says each separate violating email can carry penalties up to $53,088. See our CAN-SPAM setup post.

What does HIPAA add when you text your own patients?

If your med spa is a covered entity, 45 CFR 164.501 defines marketing as a communication about a product or service that “encourages recipients of the communication to purchase or use the product or service.” Exceptions include communications to “describe a health-related product or service” provided by the covered entity, but those exceptions fail “where the covered entity receives financial remuneration in exchange for making the communication.” The definition says financial remuneration means “direct or indirect payment from or on behalf of a third party whose product or service is being described” (45 CFR 164.501). When marketing applies, 164.508(a)(3) requires written authorization, with narrow exceptions.

We read that as a prompt to check any arrangement where a manufacturer pays or funds your outreach. Whether a given text is marketing, and whether you are a covered entity at all, are questions for a healthcare attorney. Our HIPAA answer explains covered-entity status.

How do you treat different message types?

This table is a starting framework, not a legal conclusion.

Message	Risk areas to check	GoHighLevel choice
Appointment confirmation or reminder: date, time, place	Whether any promotional content makes it marketing	Keep it to logistics. See appointment vs marketing text consent.
Promotional text naming a drug, dose or price	Written consent, A2P category, state board price and claim rules, FDA applicability unclear	Do not send until counsel clears wording. Registered campaign must match.
Promotional email about a treatment	CAN-SPAM, FTC claims, state board, FDA applicability unclear	Unsubscribe link on, address in footer, counsel-approved copy.
Message funded or supplied by a manufacturer	HIPAA marketing and remuneration, any program terms	Counsel review before building.
Post-treatment follow-up	Clinical detail in a text, PHI	Keep clinical detail out of texts. See templates without PHI.

What should you ask counsel and the state medical board?

Bring these questions:

1. Does FDA’s prescription drug advertising framework apply to our own emails and texts about injectables, and if so how?
2. What wording does our state board allow for treatment names, prices, photos and testimonials?
3. Is our practice a HIPAA covered entity, and which of our messages are marketing under 164.501?
4. How should our A2P campaign description and sample messages be written given HighLevel’s disallowed category?
5. Does any manufacturer or loyalty program we use change these answers?

What did we not verify?

• We found no FDA page saying how prescription drug advertising rules apply to a clinic’s own promotion. We did not read the full text of 21 CFR 202.1 beyond the paragraphs quoted.
• The FTC guidance sections we read did not address prescription drug advertising.
• HighLevel’s article shows no update date and does not say how disallowed categories apply to healthcare clinics.
• We opened only California among state boards, and its article is undated.

Founder’s note, Alpit Patel. I get asked whether you can text about Botox every week. Write the A2P campaign description around appointment logistics before you register. HighLevel lists prescription drugs as a disallowed category, and that cannot be resubmitted unchanged. I’d keep drug names, doses and prices out of sample messages until counsel and your state board clear the wording. No FDA page opened here says how drug-ad rules reach a clinic’s own promotion. I founded aibrevo in San Francisco in 2021, and through autoesta I have overseen 320+ GoHighLevel implementation projects across med spas, real estate, healthcare, dental, home services, SaaS and professional-services clients in the US, UK and UAE. About Alpit

Sources

All checked 2026-10-15.

• FDA, FDA Warns Companies Over Illegal Marketing of Botox and Related Products, November 5, 2025: prescription status of approved botulinum toxin products.
• FDA, Office of Prescription Drug Promotion: mission, sponsors, no mention of providers.
• eCFR, 21 CFR 202.1: manufacturer, packer or distributor language, reminder ads.
• FTC, Health Products Compliance Guidance, December 2022: substantiation, testimonials, FDA and FTC roles.
• FTC, CAN-SPAM Act compliance guide: requirements and penalty.
• eCFR, 47 CFR 64.1200: written consent, revocation, hours.
• eCFR, 45 CFR 164.501 and 164.508: marketing definition, authorization.
• HighLevel Support, A2P campaign rejection reasons and required fixes: codes 30941 and 30962.
• Medical Board of California, medical spas article: example of state points, undated.